Log In
Print
BCIQ
Print
Print this Print this
 

IPP-204106

  Manage Alerts
Collapse Summary General Information
Company ImmuPharma plc
DescriptionNucleolin antagonist
Molecular Target Nucleolin
Mechanism of ActionBinds nucleolin
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today